Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001209191-23-007782

Chief Financial Officer acquired 45,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jorgensen Nathan D. Chief Financial Officer 2023-02-06 Grant or award +45,500 160,769 D
Derivatives
Jorgensen Nathan D. Chief Financial Officer 2023-02-06 Grant or award · Employee Stock Option (right to buy) +91,000 91,000 D
Loading xslF345X03/doc4.xml…